vertex pharmaceuticals

Shares of Vertex Pharmaceuticals Under Pressure, Down 1.9%

Published on Mon, 05/20/2013 - 12:33
By Peter Chu in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Peter Chu
pchu@fnno.com

Vertex Pharmaceuticals Earnings Review: 18 Days after Announcement Shares Up 3.5% (VRTX)

Published on Sat, 05/18/2013 - 09:25
By Robert Cotter in Earnings Lookback, vrtx, earnings flashbacks, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Stock Investors Sell Off Shares of Vertex Pharmaceuticals, Down 1.8%

Published on Wed, 05/15/2013 - 10:23
By Peter Chu in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Peter Chu
pchu@fnno.com

Vertex Pharmaceuticals Shares Climbing Higher, Up 1.4%

Published on Thu, 05/09/2013 - 12:32
By Robert Cotter in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Stock Investors Bid Up Shares of Vertex Pharmaceuticals, Up 2.3%

Published on Mon, 05/06/2013 - 12:24
By Mallory Stone in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Mallory Stone
mstone@fnno.com

Relatively Good Performance Detected in Shares of Regeneron Pharmaceuticals in the Biotechnology Industry (REGN, AMGN, VRTX, SNTA, ARNA)

REGN

By Peter Chu
pchu@fnno.com

Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)

Published on Wed, 05/01/2013 - 11:12
By Robert Cotter in Moving average crossovers, vrtx, moving crosses, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Shares of Vertex Pharmaceuticals Under Pressure, Down 1.8%

Published on Tue, 04/30/2013 - 12:45
By Robert Cotter in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Vertex Pharmaceuticals Up 51.9% Since Canaccord Genuity Upgraded One Week Ago (VRTX)

Published on Fri, 04/26/2013 - 09:12
By Adrienne Chilton in Analyst reflections, vrtx, analyst reflections, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Adrienne Chilton
achilton@fnno.com

Vertex Pharmaceuticals In Retrospect: Shares Up 51.9% Since Upgraded One Week Ago (VRTX)

Published on Fri, 04/26/2013 - 09:11
By Adrienne Chilton in Analyst reflections, vrtx, analyst reflections, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Analyst Rating In Review: Molson Coors B...

One week ago Molson Coors Brewing (NYSE:TAP) was upgraded from Hold to Buy at Stifel. ...

Beam Down 1.4% Since Stifel Upgraded One...

A week ago, Stifel upgraded Beam from Hold to Buy. Beam shares are selling at $67.64, ...

Constellation Brands Fulfills the Promis...

A week ago, Stifel upgraded Constellation Brands from Hold to Buy. Constellation Brand ...

Coca-Cola Enterprises Down 2.8% Since St...

Stifel downgraded Coca-Cola Enterprises (NYSE:CCE) from Buy to Hold a week ago. The sh ...

Interactive Intelligence Down 5.0% Since...

One week ago Interactive Intelligence (NASDAQ:ININ) was downgraded from Outperform to M ...

Crane Down 0.5% Since Ascendiant Capital...

Ascendiant Capital downgraded Crane (NYSE:CR) from Buy to Neutral a week ago. Crane sh ...

Stephens Made the Right Call, Stoneridge...

One week ago Stoneridge (NYSE:SRI) was upgraded from Equal Weight to Overweight at Step ...

Analyst Rating In Review: Chesapeake Ene...

One week ago Chesapeake Energy (NYSE:CHK) was downgraded from Overweight to Neutral at ...

Most Popular Video News